Publisher
Springer Science and Business Media LLC
Reference58 articles.
1. Amina B, Lynda AK, Sonia S, Adel B, Jelloul BH, Miloud M, Tewfik S et al (2021) Fibroblast growth factor receptor 1 protein (fgfr1) as potential prognostic and predictive marker in patients with luminal b breast cancers overexpressing human epidermal receptor 2 protein (her2). Indian J Pathol Microbiol 64(2):254
2. Asperti A, Trentin M (2020) Balancing reconstruction error and kullback-leibler divergence in variational autoencoders. IEEE Access 8:199,440–199,448
3. Berrar D (2019) Cross-validation
4. Bi K, He MX, Bakouny Z, Kanodia A, Napolitano S, Wu J, Grimaldi G, Braun DA, Cuoco MS, Mayorga A et al (2021) Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma. Cancer Cell 39(5):649–661
5. Bouchalova K, Kharaishvili G, Bouchal J, Vrbkova J, Megova M, Hlobilkova A (2014) Triple negative breast cancer-bcl2 in prognosis and prediction. review. Current drug targets 15(12):1166–1175